Syn2bio (WAR:S2B) EPS (Diluted): zł (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:S2B Syn2bio SA WAR:S2B
11 GF Score
Price zł81.40
! 2 Warning Signs
View Full Analysis

What is Syn2bio EPS (Diluted)?

Syn2bio WAR:S2B +1.88% 11 EPS (Diluted) is zł as of Sep. 2025. GuruFocus rates WAR:S2B with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Syn2bio's Earnings per Share (Diluted) for the six months ended in Sep. 2025 was zł-2.71.

Syn2bio's EPS (Basic) for the six months ended in Sep. 2025 was zł-2.71.

Syn2bio's EPS without NRI for the six months ended in Sep. 2025 was zł-2.71.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Syn2bio  (WAR:S2B) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Syn2bio EPS (Diluted) Related Terms

Syn2bio EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Syn2bio's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syn2bio EPS (Diluted) Chart

Syn2bio Annual Data
Trend Sep23 Sep24 Sep25
EPS (Diluted)
-1.36 -1.87 -2.71

Syn2bio Semi-Annual Data
Sep23 Sep24 Sep25
EPS (Diluted) -1.36 -1.87 -2.71

WAR:S2B vs VRTX, REGN, ALNY: EPS (Diluted) Comparison

For the Biotechnology subindustry, Syn2bio's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syn2bio PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syn2bio's PE Ratio distribution charts can be found below:

* The bar in red indicates where Syn2bio's PE Ratio falls into.


WAR:S2B
11GF Score
Syn2bio SA WAR:S2B
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syn2bio EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Syn2bio's Diluted EPS for the fiscal year that ended in Sep. 2025 is calculated as

Diluted EPS (A: Sep. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-23.661-0)/8.729
=-2.71

Syn2bio's Diluted EPS for the quarter that ended in Sep. 2025 is calculated as

Diluted EPS (Q: Sep. 2025 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-23.661-0)/8.729
=-2.71

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of zł mean?
Syn2bio (WAR:S2B) has a EPS (Diluted) of zł as of Sep. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Syn2bio and its competitors.
Is Syn2bio's EPS (Diluted) too high?
Syn2bio's current EPS (Diluted) is zł. Overall, Syn2bio has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Syn2bio's EPS (Diluted) compare to VRTX and REGN?
Syn2bio's EPS (Diluted) of zł can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Biotechnology company?
A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Syn2bio and its competitors. Syn2bio's current EPS (Diluted) is zł. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syn2bio stock overvalued right now?
Syn2bio (WAR:S2B) has a current EPS (Diluted) of zł. The current EPS (Diluted) is zł. Syn2bio's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Syn2bio (WAR:S2B), the current EPS (Diluted) is zł as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syn2bio Business Description

Address ul. Jozefa Piusa Dziekonskiego 3, Warszawa, POL, 00-728
Syn2bio SA is a Polish biotech company that develops radiopharmaceuticals. It specializes in developing a cardiac biomarker for diagnosing heart conditions like coronary artery disease through myocardial perfusion imaging. The company's flagship product is the SYN2 cardiotracer. It is applied in the detection of perfusion disorders, evaluation of patients after myocardial infarction or with ischemic heart disease, and assessment of atherosclerotic changes in coronary arteries.
11GF Score

Get the complete analysis for WAR:S2B

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł81.40
Price